CMP weakens the antioxidant defense capacity of tumor cells by downregulating the Nrf2/HO-1/xCT/GPX4 signaling pathway, thereby inducing lipid peroxidation and ROS accumulation, and ultimately leading to ferroptosis. This evidence concerns the gene GPX4 and neoplasm.